FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149770029> ?p ?o ?g. }

• W2149770029 endingPage "810" @default.
• W2149770029 startingPage "804" @default.
• W2149770029 abstract "Introduction: The immunopathogenesis of multiple sclerosis (MS) is a main field of research, together with the mechanism of action of most immune therapies in this disease, such as interferon beta. Interleukin (IL)-17 is considered to play a central part in the initial immune cascade in MS, though there are numerous interactions between other cytokines that might explain the heterogeneity of disease evolution and treatment response. Material and Methods: We tested the serum levels of IL-17A, IL-10 and transforming growth factor (TGF-β) using the enzyme-linked immunosorbent assay method in three small groups of relapsing-remitting MS patients: 10 being naïve without treatment, 10 patients receiving Avonex treatment early in the MS evolution (≤ one year from the MS onset) and 12 MS patients who received Avonex later in the disease evolution. The values were compared with those obtained from 32 healthy subjects using statistical analysis. Results: In the naive multiple sclerosis group: IL-17A values were statistically higher than among healthy subjects; IL- 17A inversely correlated with MS duration; serum IL-17A negatively correlated with TGF-β. A direct correlation was found between the serum titre of IL-17A and IL-10 in the early treated multiple sclerosis group; the titre of IL-17A was significantly reduced compared with that from the late treated multiple sclerosis group. Conclusion: The role in MS pathology of IL-17A, IL-10 and TGF-β is only partially elucidated. IL-17 plays an important role in the inflammatory phase of relapsing-remitting MS and is diminished by Avonex mainly if this disease modifying treatment is administered early in the evolution of MS. Keywords: Immunopathology, interleukin-17, interleukin-10, multiple sclerosis, transforming growth factor-β." @default.
• W2149770029 created "2016-06-24" @default.
• W2149770029 creator A5007143606 @default.
• W2149770029 creator A5032793277 @default.
• W2149770029 creator A5032878846 @default.
• W2149770029 creator A5076066249 @default.
• W2149770029 creator A5076789072 @default.
• W2149770029 creator A5084165671 @default.
• W2149770029 date "2015-06-24" @default.
• W2149770029 modified "2023-10-18" @default.
• W2149770029 title "An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β" @default.
• W2149770029 cites W1538907359 @default.
• W2149770029 cites W1964826416 @default.
• W2149770029 cites W1978330691 @default.
• W2149770029 cites W1985031703 @default.
• W2149770029 cites W1985256844 @default.
• W2149770029 cites W1991493014 @default.
• W2149770029 cites W2014454642 @default.
• W2149770029 cites W2017332009 @default.
• W2149770029 cites W2023102395 @default.
• W2149770029 cites W2033461650 @default.
• W2149770029 cites W2041047981 @default.
• W2149770029 cites W2062538967 @default.
• W2149770029 cites W2065620817 @default.
• W2149770029 cites W2067998744 @default.
• W2149770029 cites W2076772239 @default.
• W2149770029 cites W2077990172 @default.
• W2149770029 cites W2078621743 @default.
• W2149770029 cites W2092414360 @default.
• W2149770029 cites W2097177736 @default.
• W2149770029 cites W2100319096 @default.
• W2149770029 cites W2102158172 @default.
• W2149770029 cites W2111588724 @default.
• W2149770029 cites W2114403636 @default.
• W2149770029 cites W2122545833 @default.
• W2149770029 cites W2125666654 @default.
• W2149770029 cites W2127314160 @default.
• W2149770029 cites W2133139545 @default.
• W2149770029 cites W2139321499 @default.
• W2149770029 cites W2139506607 @default.
• W2149770029 cites W2144013613 @default.
• W2149770029 cites W2167110087 @default.
• W2149770029 cites W2167966811 @default.
• W2149770029 cites W2180194522 @default.
• W2149770029 cites W2184949830 @default.
• W2149770029 doi "https://doi.org/10.2174/1871527314666150317225441" @default.
• W2149770029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25801840" @default.
• W2149770029 hasPublicationYear "2015" @default.
• W2149770029 type Work @default.
• W2149770029 sameAs 2149770029 @default.
• W2149770029 citedByCount "5" @default.
• W2149770029 countsByYear W21497700292014 @default.
• W2149770029 countsByYear W21497700292017 @default.
• W2149770029 countsByYear W21497700292019 @default.
• W2149770029 countsByYear W21497700292020 @default.
• W2149770029 crossrefType "journal-article" @default.
• W2149770029 hasAuthorship W2149770029A5007143606 @default.
• W2149770029 hasAuthorship W2149770029A5032793277 @default.
• W2149770029 hasAuthorship W2149770029A5032878846 @default.
• W2149770029 hasAuthorship W2149770029A5076066249 @default.
• W2149770029 hasAuthorship W2149770029A5076789072 @default.
• W2149770029 hasAuthorship W2149770029A5084165671 @default.
• W2149770029 hasConcept C118131993 @default.
• W2149770029 hasConcept C126322002 @default.
• W2149770029 hasConcept C159654299 @default.
• W2149770029 hasConcept C187316574 @default.
• W2149770029 hasConcept C203014093 @default.
• W2149770029 hasConcept C2778690821 @default.
• W2149770029 hasConcept C2779134260 @default.
• W2149770029 hasConcept C2780640218 @default.
• W2149770029 hasConcept C32611913 @default.
• W2149770029 hasConcept C47348012 @default.
• W2149770029 hasConcept C71924100 @default.
• W2149770029 hasConcept C74172505 @default.
• W2149770029 hasConcept C8891405 @default.
• W2149770029 hasConcept C90924648 @default.
• W2149770029 hasConceptScore W2149770029C118131993 @default.
• W2149770029 hasConceptScore W2149770029C126322002 @default.
• W2149770029 hasConceptScore W2149770029C159654299 @default.
• W2149770029 hasConceptScore W2149770029C187316574 @default.
• W2149770029 hasConceptScore W2149770029C203014093 @default.
• W2149770029 hasConceptScore W2149770029C2778690821 @default.
• W2149770029 hasConceptScore W2149770029C2779134260 @default.
• W2149770029 hasConceptScore W2149770029C2780640218 @default.
• W2149770029 hasConceptScore W2149770029C32611913 @default.
• W2149770029 hasConceptScore W2149770029C47348012 @default.
• W2149770029 hasConceptScore W2149770029C71924100 @default.
• W2149770029 hasConceptScore W2149770029C74172505 @default.
• W2149770029 hasConceptScore W2149770029C8891405 @default.
• W2149770029 hasConceptScore W2149770029C90924648 @default.
• W2149770029 hasIssue "6" @default.
• W2149770029 hasLocation W21497700291 @default.
• W2149770029 hasLocation W21497700292 @default.
• W2149770029 hasOpenAccess W2149770029 @default.
• W2149770029 hasPrimaryLocation W21497700291 @default.
• W2149770029 hasRelatedWork W1978675331 @default.
• W2149770029 hasRelatedWork W1996719699 @default.
• W2149770029 hasRelatedWork W2100319096 @default.

• next